Correlation Between GlaxoSmithKline PLC and BERKSHIRE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and BERKSHIRE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and BERKSHIRE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and BERKSHIRE HATHAWAY FIN, you can compare the effects of market volatilities on GlaxoSmithKline PLC and BERKSHIRE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of BERKSHIRE. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and BERKSHIRE.

Diversification Opportunities for GlaxoSmithKline PLC and BERKSHIRE

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between GlaxoSmithKline and BERKSHIRE is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and BERKSHIRE HATHAWAY FIN in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BERKSHIRE HATHAWAY FIN and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with BERKSHIRE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BERKSHIRE HATHAWAY FIN has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and BERKSHIRE go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and BERKSHIRE

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the BERKSHIRE. In addition to that, GlaxoSmithKline PLC is 1.04 times more volatile than BERKSHIRE HATHAWAY FIN. It trades about -0.28 of its total potential returns per unit of risk. BERKSHIRE HATHAWAY FIN is currently generating about -0.03 per unit of volatility. If you would invest  10,854  in BERKSHIRE HATHAWAY FIN on August 26, 2024 and sell it today you would lose (137.00) from holding BERKSHIRE HATHAWAY FIN or give up 1.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  BERKSHIRE HATHAWAY FIN

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
BERKSHIRE HATHAWAY FIN 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BERKSHIRE HATHAWAY FIN has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, BERKSHIRE is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and BERKSHIRE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and BERKSHIRE

The main advantage of trading using opposite GlaxoSmithKline PLC and BERKSHIRE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, BERKSHIRE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BERKSHIRE will offset losses from the drop in BERKSHIRE's long position.
The idea behind GlaxoSmithKline PLC ADR and BERKSHIRE HATHAWAY FIN pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets